Abstract
Castleman’s disease (CD) is a highly heterogeneous clinico-pathological entity belonging to the lymphoproliferative disorders. CD can occur in any part of the human body where lymph nodes are present. In addition, very few cases have been reported in hepatic hilum. Here, we present a case of a middle-aged female patient who was presented with abdominal pain and diagnosed as localized Castleman’s disease of hepatic hilar and retroperitoneal origin. Diagnosing CD is complex due to its resemblance to many other diseases. EUS and FNA may play a more important role in differential diagnosis of CD and other disease in digestive system.
Similar content being viewed by others
References
Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128:657–62.
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9:822–30.
Hakozaki M, Tajino T, Yamada H, et al. Intramuscular Castleman’s disease of the deltoid: a case report and review of the literature. Skeletal Radiol. 2010;39:715–9.
Nishi J, Maruyama I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman’s disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma. 2000;38:387–94.
Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16:236–46.
Munshi NMM, van de Velde H, Desai A, et al. Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma. 2015;56:1252–60.
Waterston ABM. Fifty years of multicentric Castleman’s disease. Acta Oncol. 2004;43:698–704.
Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3–17.
Jang SY et al. A case of Castleman’s Disease mimicking a hepatocellular carcinoma: a case report and review of literature. Korean J Gastroenterol. 2012;59(1), 53–57.
Geramizadeh B, Fattahi MR, Lankarani KB, et al. Castleman’s disease of the porta hepatis: an uncommon disease with atypical recurrence. Middle East J Dig Dis. 2012;4:180–2.
Ogoshi T, Kido T, Yatera K, et al. Assessment of pathologically diagnosed patients with Castleman’s Disease associated with Diffuse Parenchymal Lung Involvement Using the Diagnostic Criteria for IgG4-Related Disease. Lung. 2013;191:575–83.
Kuchelan Deepa A Sea. Multicentric Castleman Disease: a lymphoma mimic in an immunocompetent patient. Chest. 2016;146(4):617A.
Filliatre-Clement L, Busby-Venner H, Moulin C, et al. Hodgkin lymphoma and Castleman disease: when one blood disease can hide another. Case Rep Hematol. 2017;2017:9423205.
Cirillo RL, et al. Castleman disease mimicking a hepatic neoplasm. Clin Imaging. 1998;22(2):124–9. https://doi.org/10.1016/S0899-7071(97)00096-X.
Lv K, Zhao Y, Xu W, Zhang C, Huang P. Ultrasound and radiological features of abdominal unicentric castleman’s disease: a case series study. Medicine. 2020;99:18(e20102).
Ogoshi T, Kido T, Yatera K, Oda K, Kawanami T, Ishimoto H, et al. Assessment of pathologically diagnosed patients with castleman’s disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease. Lung. 2013;191(6):575–83.
Chronowski M, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001;92:670–6.
Neuhof DDJ. Outcome and late complications of radio- therapy in patients with unicentric Castleman disease. Acta Oncol. 2006;45:1126–31.
Li YM, Liu PH, Zhang YH, et al. Radiotherapy of unicentric medias- tinal Castleman’s disease. Chin J Cancer. 2011;30:351–6.
Matthiesen C, Ramgopol R, Seavey J, et al. Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature. Radiol Oncol. 2012;46:265–70.
Miranda FA, Faria VH et al. Radiation therapy in the treatment of unicentric Castleman’s disease. J Bras Pneumol. 2013;39:116–118.
Acknowledgements
This work was supported by grants from National Natural Science Foundation of China (No. 81602432).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
There is no conflict of all the authors in financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated.
Informed consent
The patient has provided informed consent for publication of the case, and the Ethics Review Board of Zhongda Hospital of Nanjing City approved the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yin, Y., Yu, T. & Mulmi Shrestha, S. Unicentric Castleman’s disease of hepatic hilum and retroperitoneum: a case report for endoscopic ultrasonography differential diagnosis and a literature review. Clin J Gastroenterol 14, 1250–1254 (2021). https://doi.org/10.1007/s12328-021-01418-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-021-01418-2